Navigation Links
Targeted investigational therapy potential to overcome crizotinib resistance in lung cancers
Date:10/20/2013

BOSTON PF-06463922, an investigational drug being developed by Pfizer Inc., has the potential to become a new treatment option for patients who have lung cancer harboring abnormalities in the ALK gene, according to preclinical results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.

About 3 to 5 percent of lung cancers harbor ALK gene abnormalities. The drug crizotinib (Xalkori), which blocks ALK protein kinase activity, was approved in August 2011 by the U.S. Food and Drug Administration for the treatment of patients who have these lung cancers. Although robust responses to crizotinib are observed for lung cancers harboring ALK gene abnormalities, the majority eventually become resistant to the effects of the drug. In many cases, resistance arises because of genetic mutations in ALK.

"Resistance to targeted therapies such as crizotinib is a major challenge when treating patients with cancer," said Tod Smeal, Ph.D., associate research fellow in the Oncology Research Unit at Pfizer Inc. in San Diego, Calif. "Our goal is to take advantage of everything we have learned about designing drugs that target kinases like ALK and the ways in which lung cancers become resistant to crizotinib to develop the best next-generation ALK inhibitor we can.

"Our preclinical studies suggest that we are making progress toward achieving our goal: PF-06463922 has potent ALK-inhibiting activity, it is capable of inhibiting all the crizotinib-resistant ALK mutants so far detected in patients, and it can efficiently access the brain. We are excited about these preclinical results and very hopeful that they will translate into meaningful responses in the clinic."

After carefully designing PF-06463922, Smeal and colleagues first showed in cell assays that it potently inhibited the activity of ALK and all eight of the mutant forms of ALK known to cause resistance to crizotinib
'/>"/>

Contact: Lauren Riley
lauren.riley@aacr.org
215-446-7155
American Association for Cancer Research
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Targeted therapeutics for colon cancer to be presented at AACR meeting
2. First targeted nanomedicine to enter human clinical studies
3. Highly targeted irradiation as good as whole breast radiotherapy in early stage cancer
4. Dana-Farber: Study reports first success of targeted therapy in type of non-small cell lung cancer
5. Inflammatory pathway spurs cancer stem cells to resist HER2-targeted breast cancer treatment
6. Killer infections targeted by hospital study
7. Lower risk of serious side-effects in trials of new targeted drugs
8. Treating drug resistant cancer through targeted inhibition of sphingosine kinase
9. Pitt: Targeted oxidation-blocker prevents secondary damage after traumatic brain injury
10. Deadly witch hunts targeted by grassroots womens groups
11. Large lung cancer study shows potential for more targeted therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... (August 1, 2014)The use of electronic reminders such as ... getting surgical patients to adhere to a preadmission antiseptic ... site infections (SSIs), according to a first-of-its-kind study published ... the American College of Surgeons . , Each year ... rate approaching nearly 100,000 according to data sources cited ...
(Date:8/1/2014)... 2014 Chilton Medical Center has ... to empower patients and their families to take ... by providing easy, secure access to their medical ... web-based access to their health information at Chilton ... allergies, demographic information, visit history, discharge/aftercare information, and ...
(Date:8/1/2014)... 01, 2014 Ticket Down is a reputable ... Lane Farms in Knoxville/Greenback, TN; Ingram Farms in Auburn/Opelika, AL; ... in Archer/Gainesville, FL. Luke Bryan is currently out on his ... and Cole Swindell. Bryan is responsible for one of the ... and this year, just because the summer is over doesn’t ...
(Date:8/1/2014)... 2014 With fast food restaurants on almost ... of processed, microwavable dinners, it is no wonder that America ... patients a mere quick fix for shedding this dangerous excess ... of the country, get slimmer and healthier for the long ... tools and education on how to avoid obesity , ...
(Date:8/1/2014)... A new study published in ... contribute to the development of colorectal cancer in patients ... study was authored by Alberto Martin of the University ... intestinal cells to multiply and create tumors in mice ... , “What’s interesting about this study,” said Shahab Mehdizadeh, ...
Breaking Medicine News(10 mins):Health News:Electronic reminders can help patients prevent surgical site infections 2Health News:Electronic reminders can help patients prevent surgical site infections 3Health News:Chilton Medical Center Launches Online Patient Portal 2Health News:Luke Bryan Tickets at Maple Lane Farms in Knoxville, Ingram Farms in Auburn, Cross Creek Place in Tallahassee & Whitehurst Cattle Farm in Gainesville Now Available 2Health News:Luke Bryan Tickets at Maple Lane Farms in Knoxville, Ingram Farms in Auburn, Cross Creek Place in Tallahassee & Whitehurst Cattle Farm in Gainesville Now Available 3Health News:Luke Bryan Tickets at Maple Lane Farms in Knoxville, Ingram Farms in Auburn, Cross Creek Place in Tallahassee & Whitehurst Cattle Farm in Gainesville Now Available 4Health News:Diet Doc Medical Weight Loss Programs Announces Diet Plans That Melt Excess Fat Rapidly While Teaching Patients How to Avoid Obesity 2Health News:Diet Doc Medical Weight Loss Programs Announces Diet Plans That Melt Excess Fat Rapidly While Teaching Patients How to Avoid Obesity 3Health News:Carbs May Contribute to Colon Cancer 2
... OCTOBER 15, 2007 -- The Cardiovascular Research ... research study, HORIZONS AMI (Harmonizing Outcomes with Revascularization ... nineteenth annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium ... examine the safety and effectiveness of stents and ...
... decline over past decade , , MONDAY, Oct. 15 (HealthDay News) ... the United States, offering what an expert called a "glimmer ... new report, cancer death rates fell by 2.1 percent each ... percent annual decline recorded between 1993 and 2003. , "That,s ...
... 2007 New research presented at the 72nd ... Gastroenterology emphasizes the importance of colorectal cancer (CRC) ... a higher incidence of colorectal cancer compared to ... advanced polyps on the right side of the ...
... 2007 Using a model to predict reductions ... researchers from Memorial Sloan-Kettering looked at the relative ... pre-cancerous polyps from the colon versus surveillance follow-up ... Winawer, M.D., MACG and colleagues presented their findings ...
... A new analysis of randomized controlled trials ... syndrome (IBS) has found that Bifantis, Bifidobacterium infantis ... Procter & Gamble), is the only probiotic currently ... based upon a properly designed research study. Researchers ...
... 15 Level I and II,Trauma Center accreditation status has ... 15, 2007 through,September 30, 2008: Regional Resource Trauma Center ... Hospital Johnstown -- Conemaugh Memorial Medical ... Center Philadelphia -- Hahnemann University Hospital ...
Cached Medicine News:Health News:Horizons AMI trial data to be presented at TCT 2007 2Health News:U.S. Cancer Death Rate Continues to Fall 2Health News:U.S. Cancer Death Rate Continues to Fall 3Health News:Racial and ethnic differences in colorectal cancer emphasize importance of screening 2Health News:First colonoscopy with removal of polyps linked to reduction in colon cancer death 2Health News:First colonoscopy with removal of polyps linked to reduction in colon cancer death 3Health News:Review of probiotic research finds only Bifantis can claim efficacy vs. placebo for IBS symptoms 2Health News:Pennsylvania Trauma Center Accreditation Status 2
(Date:7/31/2014)... , July 31, 2014  Decision ... changes brought about by the Affordable Care ... and prescribing of pharmaceutical therapies. The ACA ... beneficiaries through new regulations and expanded access ... in the health exchanges—state-based marketplaces set up ...
(Date:7/31/2014)... BURLINGTON, Mass. , July 31, 2014 /PRNewswire/ ... committee members—who make decisions about which therapies are ... influence formulary placement, according to a new Manhattan ... Makers 2014 . The study finds that P&T ... and pharmacy benefits managers (PBMs) have set a ...
(Date:7/31/2014)... -- Lazarus Effect, a medical device company focused on ... of blood clots, announced the closing of a $5 ... commercialization of several approved Lazarus Effect devices, as well ... Cover™ in the United States . ... value of our novel, platform technology as well as ...
Breaking Medicine Technology:Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 2Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 3Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 4Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 2Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 3Lazarus Effect Closes $5 Million Financing 2
... 14, 2011 OCuSOFT, Inc., an ophthalmic pharmaceutical research, ... agreement with Ardeo Health, LLC to distribute a novel ... of Evry, France, Nova23041. Nova23041 will be ... as Retaine® MGD™ Ophthalmic Emulsion under a brand license ...
... Better Health ™, a program of Lilly USA, LLC, ... healthier, more active lives, launches an enhanced multi-channel platform ... health information. The platform includes an array of patient ... manage their health, a dynamic website – lillyforbetterhealth.com ...
Cached Medicine Technology:Dry Eye Therapy Utilizing Cationic Novasorb® Technology Available Soon From OCuSOFT® 2Dry Eye Therapy Utilizing Cationic Novasorb® Technology Available Soon From OCuSOFT® 3Lilly for Better Health™ Launches Enhanced Multi-Channel Patient Education Platform 2Lilly for Better Health™ Launches Enhanced Multi-Channel Patient Education Platform 3
Idophor PVP Scrub Winged Sponges...
... E*Kits® can be a valuable tool in ... the items necessary for a procedure are ... and continuum of care are easier to ... in sequence of use, allowing the clinician ...
Triad Plus PVP-I Scrub Winged Sponges...
... wet trays to dry trays to specialty ... trays, Cardinal Health offers the widest offering ... contain components that are proven to be ... risk of surgical site infections. Cardinal Health ...
Medicine Products: